Harbor Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
6,049
+13
+0.2% +$4.45K 0.15% 193
2026
Q1
$2.12M Buy
+6,036
New +$2.15M 0.17% 165
2025
Q1
Sell
-11,712
Closed -$3.05M 1410
2024
Q4
$3.05M Buy
11,712
+285
+2% +$84.6K 0.13% 213
2024
Q3
$3.68M Buy
11,427
+54
+0.5% +$17.7K 0.16% 189
2024
Q2
$3.55M Buy
11,373
+22
+0.2% +$6.46K 0.27% 94
2024
Q1
$3.23M Buy
11,351
+1,729
+18% +$506K 0.42% 33
2023
Q4
$2.77M Sell
9,622
-13
-0.1% -$3.54K 0.53% 35
2023
Q3
$2.59M Hold
9,635
0.55% 34
2023
Q2
$2.14M Hold
9,635
0.43% 50
2023
Q1
$2.33M Buy
+9,635
New +$2.37M 0.67% 44

Other funds holding AMGN

Harbor Capital Advisors's AMGN Position: Q2 2026 in Review

Harbor Capital Advisors increased its Amgen (AMGN) stake by 0.22% in Q2 2026, buying an estimated $4.45K and bringing the position to 6,049 shares worth $2.19M. The position accounts for 0.15% of the portfolio, ranked #193.

Harbor Capital Advisors first reported a position in AMGN in Q1 2023 and has held it in 10 quarters since. The position peaked at $3.68M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Harbor Capital Advisors held 6,049 shares of Amgen worth $2.19M as of Q2 2026.
  • Harbor Capital Advisors bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
  • Amgen made up 0.15% of Harbor Capital Advisors's portfolio in Q2 2026, its #193 holding.
  • Harbor Capital Advisors first reported a position in Amgen in Q1 2023 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Amgen position peaked at $3.68M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.